Company Filing History:
30 out of 151 
11 out of 2,483 
11 out of 1,152 
Years Active: 1997-2025
Title: Innovations and Contributions of Wolfgang Teschner
Introduction
Wolfgang Teschner is a prominent inventor based in Vienna, Austria, known for his significant contributions to the field of biomedicine through his extensive work on plasma-derived proteins. With a remarkable portfolio of 31 patents, Teschner has made impactful advancements that address critical healthcare challenges.
Latest Patents
Two of Wolfgang Teschner's latest patents showcase his innovative approaches to enhancing medical treatments. The first patent focuses on the "Removal of serine proteases by treatment with finely divided silicon dioxide," which provides novel methods for reducing serine protease and/or serine protease zymogen content in plasma-derived protein compositions. This invention includes aqueous and lyophilized compositions aimed at improving patient safety and efficacy. Furthermore, it outlines methods for treating, managing, and preventing diseases through the administration of modified protein compositions.
The second notable patent, "Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use," presents a new and improved technique for preparing immunoglobulin compositions from pooled plasma for subcutaneous injections. This patent describes a concentrated composition of 20% or more immunoglobulin, enhancing the delivery and effectiveness of treatments utilizing these crucial proteins.
Career Highlights
Throughout his career, Wolfgang Teschner has worked with notable organizations, including Baxalta GmbH and Baxter International Inc. These companies have provided a platform for Teschner's research and development efforts, allowing him to lead innovative projects that significantly contribute to the field of immunology and therapeutic applications.
Collaborations
Collaboration has been an essential aspect of Teschner's work. He has partnered and brainstormed with talented professionals such as Hans-Peter Schwarz and Azra Pljevljakovic. Together, they have contributed to the advancement of biopharmaceutical solutions and the improvement of healthcare treatments.
Conclusion
Wolfgang Teschner's extensive patent portfolio and his pioneering work in the biomedical field underscore his role as a leading inventor. Through his innovative patents and collaborations, Teschner continues to make substantial contributions to healthcare, enhancing the effectiveness of treatments available to patients worldwide.